Table 4 Follow-up feedbacks of patients after nebulization treatment
Days from the onset of nebulization treatment | Clinical Symptoms | COVID-19 antibody test | Lymphocyte count | Alanine aminotransferase (ALT) (U/L) | Creatinine (Cr) (μmol/L) | Chest CT images | |
|---|---|---|---|---|---|---|---|
Patient 1 | Day 20 | Denied | IgM ( −), IgG ( −) | 2.29 × 109/L | N/A | N/A | Obvious absorption of infiltration at both lobes compared with the day of symptom onset |
Day 36 | Denied | N/A | N/A | N/A | N/A | Slight absorption compared with Day 20 | |
Patient 2 | Day 41 | Denied | IgM ( −), IgG ( +) | 2.14 × 109/L | 45 | 53 | Partial absorption of infiltration compared with the day of symptom onset |
Patient 3 | Day 22 | Denied | N/A | N/A | N/A | N/A | Normal |
Day 59 | Denied | N/A | 3.72 × 109/L | 9 | 63 | Normal | |
Patient 4 | Day 17 | Mild cough | N/A | N/A | N/A | N/A | Infiltration at both lobes, similar to the day of symptom onset |
Day 43 | Denied | N/A | N/A | N/A | N/A | Infiltration at both lobes, similar to Day 17 | |
Patient 5 | Day 36 | Denied | IgM ( −), IgG ( +) | 2.52 × 109/L | 20 | 55 | Slight absorption compared with the day of symptom onset |
Patient 6 | Day 24 | Mild cough | N/A | N/A | N/A | 49 | N/A |
Patient 7 | Day 28 | Denied | IgM ( −), IgG ( +) | 1.82 × 109/L | 10 | 50 | Obvious absorption of infiltration at both lobes compared with Day 2 |
Day 52 | Denied | N/A | 1.97 × 109/L | N/A | N/A | Slight absorption compared with Day 28 |